Johnson&Johnson increases bid for Actelion
US personal care products giant Johnson&Johnson has increased its takeover offer for Swiss biotech outfit Actelion as talks between the two firms progress, Bloomberg reported citing people familiar with the matter.
As of 1447 GMT shares in Actelion were down by 4.95% to 180.60 Swiss francs.
-- More to follow --